Cite
Conde J, Pumroy RA, Baker C, et al. Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression. ACS Cent Sci. 2021;7(5):868-881doi: 10.1021/acscentsci.1c00070.
Conde, J., Pumroy, R. A., Baker, C., Rodrigues, T., Guerreiro, A., Sousa, B. B., Marques, M. C., de Almeida, B. P., Lee, S., Leites, E. P., Picard, D., Samanta, A., Vaz, S. H., Sieglitz, F., Langini, M., Remke, M., Roque, R., Weiss, T., Weller, M., Liu, Y., Han, S., Corzana, F., Morais, V. A., Faria, C. C., Carvalho, T., Filippakopoulos, P., Snijder, B., Barbosa-Morais, N. L., Moiseenkova-Bell, V. Y., & Bernardes, G. J. L. (2021). Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression. ACS central science, 7(5), 868-881. https://doi.org/10.1021/acscentsci.1c00070
Conde, João, et al. "Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression." ACS central science vol. 7,5 (2021): 868-881. doi: https://doi.org/10.1021/acscentsci.1c00070
Conde J, Pumroy RA, Baker C, Rodrigues T, Guerreiro A, Sousa BB, Marques MC, de Almeida BP, Lee S, Leites EP, Picard D, Samanta A, Vaz SH, Sieglitz F, Langini M, Remke M, Roque R, Weiss T, Weller M, Liu Y, Han S, Corzana F, Morais VA, Faria CC, Carvalho T, Filippakopoulos P, Snijder B, Barbosa-Morais NL, Moiseenkova-Bell VY, Bernardes GJL. Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression. ACS Cent Sci. 2021 May 26;7(5):868-881. doi: 10.1021/acscentsci.1c00070. Epub 2021 Apr 14. PMID: 34079902; PMCID: PMC8161495.
Copy
Download .nbib